Interpace Diagnostics

Interpace Diagnostics is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States through its Commercial Services business, and developing and commercializing molecular diagnostic tests through its Interpace Diagnostics business. Interpace Diagnostics's Commercial Services is focused on providing outsourced pharmaceutical, biotechnology, medical device and diagnostic sales teams to its corporate customers. Interpace Diagnostics's Interpace Diagnostics is focused on developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for better patient diagnosis and management.

Parsippany-Troy Hills, US
775 (est)
Interpace Diagnostics was founded in 1987 and is headquartered in Parsippany-Troy Hills, US

Interpace Diagnostics Locations

Parsippany-Troy Hills, US

Interpace Diagnostics Metrics

Interpace Diagnostics Summary

Market capitalization

$9.77 M

Closing share price

Interpace Diagnostics's current market capitalization is $9.77 M.

Interpace Diagnostics Market Value History

Interpace Diagnostics Online Presence

Interpace Diagnostics News

Interpace Diagnostics Company Life

You may also be interested in